Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Redfield

Showing results (221-230 of 336) with videos related to

Pageof 34
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1988
Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genomeZ Matsuda, M J Chou, M Matsuda, et al.
AIDS (London, England)|February 1, 1996
V3 seroreactivity and sequence variation: tracking the emergence of V3 genotypic variation in HIV-1-infected patientsN L Michael, K E Davis, L D Loomis-Price, et al.
Transplantation|December 8, 2017
Complete B Cell Deficiency Reduces Allograft Inflammation and Intragraft Macrophages in a Rat Kidney Transplant ModelSarah E Panzer, Nancy A Wilson, Bret M Verhoven, et al.
Journal of Virology|March 1, 1995
Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohortN L Michael, T Mo, A Merzouki, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Prevalence of HIV antibody among a group of paraphilic sex offendersC Di Giovanni, F Berlin, P Casterella, et al.
Journal of Pain and Symptom Management|July 19, 2015
Implementation of HIV Palliative Care: Interprofessional Education to Improve Patient Outcomes in Resource-Constrained Settings, 2004-2012Carla S Alexander, Gregory Pappas, Anthony Amoroso, et al.
Transplantation Direct|March 15, 2018
Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney TransplantationSandesh Parajuli, Didier A Mandelbrot, Brenda Muth, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2015
Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized miceAlonso Heredia, Nhut Le, Ronald B Gartenhaus, et al.
International Journal of STD & AIDS|April 7, 2018
Patient-level outcomes and virologic suppression rates in HIV-infected patients receiving antiretroviral therapy in RwandaDavid J Riedel, Kristen A Stafford, Peter Memiah, et al.
AIDS Research and Human Retroviruses|May 18, 2019
Suppression of Active HIV-1 Infection in CD34<sup>+</sup> Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting DrugsOlga S Latinovic, Lauren M Neal, Yutaka Tagaya, et al.
Pageof 34

Showing results (221-230 of 336) with videos related to

Sort By:
Pageof 34
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1988
Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genomeZ Matsuda, M J Chou, M Matsuda, et al.
AIDS (London, England)|February 1, 1996
V3 seroreactivity and sequence variation: tracking the emergence of V3 genotypic variation in HIV-1-infected patientsN L Michael, K E Davis, L D Loomis-Price, et al.
Transplantation|December 8, 2017
Complete B Cell Deficiency Reduces Allograft Inflammation and Intragraft Macrophages in a Rat Kidney Transplant ModelSarah E Panzer, Nancy A Wilson, Bret M Verhoven, et al.
Journal of Virology|March 1, 1995
Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohortN L Michael, T Mo, A Merzouki, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Prevalence of HIV antibody among a group of paraphilic sex offendersC Di Giovanni, F Berlin, P Casterella, et al.
Journal of Pain and Symptom Management|July 19, 2015
Implementation of HIV Palliative Care: Interprofessional Education to Improve Patient Outcomes in Resource-Constrained Settings, 2004-2012Carla S Alexander, Gregory Pappas, Anthony Amoroso, et al.
Transplantation Direct|March 15, 2018
Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney TransplantationSandesh Parajuli, Didier A Mandelbrot, Brenda Muth, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2015
Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized miceAlonso Heredia, Nhut Le, Ronald B Gartenhaus, et al.
International Journal of STD & AIDS|April 7, 2018
Patient-level outcomes and virologic suppression rates in HIV-infected patients receiving antiretroviral therapy in RwandaDavid J Riedel, Kristen A Stafford, Peter Memiah, et al.
AIDS Research and Human Retroviruses|May 18, 2019
Suppression of Active HIV-1 Infection in CD34<sup>+</sup> Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting DrugsOlga S Latinovic, Lauren M Neal, Yutaka Tagaya, et al.
Pageof 34